|
TOR1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.60999999390776E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.56172902072194E-13 |
| Normal-vs-Stage2 |
2.039200E-04 |
| Normal-vs-Stage3 |
4.1752000000006E-05 |
| Normal-vs-Stage4 |
2.259600E-03 |
| Stage1-vs-Stage2 |
9.810100E-02 |
| Stage1-vs-Stage3 |
9.922000E-03 |
| Stage1-vs-Stage4 |
8.842200E-02 |
| Stage2-vs-Stage3 |
6.899000E-01 |
| Stage2-vs-Stage4 |
7.571400E-01 |
| Stage3-vs-Stage4 |
9.848000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.73400010700698E-10 |
| Normal-vs-AfricanAmerican |
3.24659999995092E-07 |
| Normal-vs-Asian |
5.357400E-04 |
| Caucasian-vs-AfricanAmerican |
4.081000E-01 |
| Caucasian-vs-Asian |
2.694600E-01 |
| AfricanAmerican-vs-Asian |
4.345600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.32150000334386E-08 |
| Normal-vs-Female |
1.21379573059244E-11 |
| Male-vs-Female |
2.962300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.457800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.46450004848242E-09 |
| Normal-vs-Age(61-80Yrs) |
1.17389997722483E-09 |
| Normal-vs-Age(81-100Yrs) |
4.014000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.161800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.592200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.037400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.086200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.785600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.229600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.04149999735625E-08 |
| Normal-vs-Grade 2 |
8.09818878622082E-12 |
| Normal-vs-Grade 3 |
2.69509999983875E-07 |
| Normal-vs-Grade 4 |
4.760600E-03 |
| Grade 1-vs-Grade 2 |
1.481510E-02 |
| Grade 1-vs-Grade 3 |
4.399200E-03 |
| Grade 1-vs-Grade 4 |
1.679450E-03 |
| Grade 2-vs-Grade 3 |
2.720300E-02 |
| Grade 2-vs-Grade 4 |
1.952000E-01 |
| Grade 3-vs-Grade 4 |
8.330000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62825308791525E-12 |
| Normal-vs-ccB subtype |
2.14819999999616E-05 |
| ccA subtype-vs-ccB subtype |
1.54877999999359E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.52800000114462E-09 |
| Normal-vs-N1 |
5.690200E-02 |
| N0-vs-N1 |
5.800400E-01 |
|
|
